350–560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma
Open Access
- 1 April 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (16) , e6629
Abstract
To retrospectively analyze the safety and efficacy of 350–560 μm gelatin sponge particles combined with single-chemotherapy drug transcatheter arterial chemoembolization (Gs-TACE) for the treatment of elderly hepatocellular carcinoma without surgical resection. Thirty elderly hepatocellular carcinoma patients without surgical resection, who received Gs-TACE in our hospital, were selected. Slowly injected gelatin sponge particles (350–560 μm)+ 10 mg lobaplatin injection into the regional embolization tumor target vessel. The Response Evaluation Criteria for Solid Tumors could be used to evaluate the tumor response after intervention surgery. Eighty-nine times of intervention TACE were conducted on the 30 patients. The average size of tumor was 8.3 cm. The median survival time was 28 months, and the 1 and 2-year survival rates were 89% and 58%, respectively. The Response Evaluation Criteria for Solid Tumors was used to evaluate the tumor response, and found that the complete response, partial response, and OR were 30%, 56.67%, and 86.67%, respectively, at 1 month after intervention surgery. The patients were divided into groups: 60 to 65 years age group (A), >65 to 75 years age group (B), and >75 years age group (C); the median survival times were 16, 32, and 33 months, respectively, and there was statistical difference between A group, B group, and C group. The analysis of prognosis factors showed that there was statistical significance in age, Barcelona Clinic Liver Cancer stage, portal vein invasion, and alpha fetal protein (AFP), and age was the protective factor. Gelatin sponge particles (350–560 μm), combined with transcatheter arterial chemoembolization, provide an alternative method for the treatment of elderly hepatocellular carcinoma without surgical resection.Keywords
This publication has 27 references indexed in Scilit:
- Younger Hepatocellular Carcinoma Patients Have Better Prognosis After Percutaneous Radiofrequency Ablation TherapyJournal of Clinical Gastroenterology, 2012
- Transarterial (chemo)embolisation for unresectable hepatocellular carcinomaCochrane Database of Systematic Reviews, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Hepatocellular Carcinoma in Older Adults: Clinical Features, Treatments, and SurvivalJournal of the American Geriatrics Society, 2011
- Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patientsHepatology Research, 2010
- Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Renal InsufficiencyJournal of Clinical Gastroenterology, 2010
- The changing pattern of epidemiology in hepatocellular carcinomaDigestive and Liver Disease, 2010
- Liver Transplantation in the United States, 1999-2008American Journal of Transplantation, 2010
- Tumor Size Predicts Vascular Invasion and Histologic GradeLiver Transplantation, 2005
- Optimal treatment strategy for elderly patients with hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2004